These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7657345)

  • 1. [Acute effects of platelet activating factor on the pulmonary circulation in rats].
    Cheng D; Chen W; Yang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):74-7. PubMed ID: 7657345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of platelet activating factor in chronic pulmonary hypertension].
    Cheng D; Chen W
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):275-8. PubMed ID: 9389061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cromakalim inhibits endothelin-1 induced pulmonary hypertension in rats].
    Cheng D; Chen W; Xiao X
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Mar; 29(1):79-81, 94. PubMed ID: 10683987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor causes pulmonary vasodilation in the rat.
    McMurtry IF; Morris KG
    Am Rev Respir Dis; 1986 Oct; 134(4):757-62. PubMed ID: 3094417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor and solute transport processes in the kidney.
    Handa RK; Strandhoy JW; Giammattei CE; Handa SE
    Am J Physiol Renal Physiol; 2003 Feb; 284(2):F274-81. PubMed ID: 12529272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal pulmonary vasodilation after exogenous platelet-activating factor.
    Accurso FJ; Abman SH; Wilkening RB; Worthen GS; Henson P
    J Appl Physiol (1985); 1991 Feb; 70(2):778-87. PubMed ID: 2022570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
    Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
    J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.
    Burhop KE; van der Zee H; Bizios R; Kaplan JE; Malik AB
    Am Rev Respir Dis; 1986 Sep; 134(3):548-54. PubMed ID: 3752711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
    Chang SW; Feddersen CO; Henson PM; Voelkel NF
    J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic platelet-activating factor induces a decrease in pulmonary vascular compliance, hydroxyproline, and loss of vascular matrix.
    Ohar JA; Waller KS; Pantano J; Demello DE; Dahms TE
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1628-34. PubMed ID: 8004322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase.
    Toga H; Hibler S; Ibe BO; Raj JU
    J Appl Physiol (1985); 1992 Dec; 73(6):2559-66. PubMed ID: 1490969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid tracheal infusion of surfactant versus bolus instillation in rabbits: effects on oxygenation, blood pressure and surfactant distribution.
    Segerer H; Scheid A; Wagner MH; Lekka M; Obladen M
    Biol Neonate; 1996; 69(2):119-27. PubMed ID: 8713657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
    Cheng D; Chen W; Jiang J
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The current status of the research on platelet activating factor and pulmonary hypertension].
    Cheng DY; Chen WB
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):49-51. PubMed ID: 8403064
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma potentiates the priming effects of endotoxin on platelet activating factor-induced pulmonary hypertension in the rabbit lung.
    Goldsmith JA; Kavanagh BP; Pearl RG
    Anesth Analg; 1996 Aug; 83(2):242-6. PubMed ID: 8694300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    Handa RK; Strandhoy JW
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The acute effect of tetrandrine pulmonary targeting microspheres on hypoxic pulmonary hypertension in rats].
    Cheng D; Chen W; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 May; 23(5):289-91. PubMed ID: 11778220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.